The IMI Joint Undertaking (IMI JU) is a public-private partnership between the European Union, represented by the European Commission and the European Federation for Pharmaceutical Industries and Associations (EFPIA).
IMI JU, formally set up by a Council decision, is the legal entity responsible for implementing the Innovative Medicines Joint Technology Initiative (IMI JTI)
The governance structure of IMI is comprised of the Joint Undertaking of three bodies:
- the IMI Governing Board
- the IMI Executive Director heading the Executive Office and
- the IMI Scientific Committee
IMI Joint Technology Initiative